FDA product code PLS: Immunohistochemistry Assay, Antibody, Programmed Death-Ligand 1

PLS is the FDA product code for immunohistochemistry assay, antibody, programmed death-ligand 1. It is a Class III device, reviewed by the Pathology panel. Devices under PLS reach the market by PMA; FDA lists no cleared 510(k)s for it. 6 PMA applications cite this product code. FDA has posted 2 recalls for PLS devices, 1 initiated in the last five years.

Definition

The programmed death-ligand 1 (PD-L1) antibody is a qualitative immunohistochemical antibody intended to identify PD-L1 protein expression in human clinical tissue specimens. The PD-L1 antibody is indicated as an aid in identifying patients eligible for treatment with specific FDA approved therapeutic drugs or to assess PD-L1 expression level in patients who may respond particularly well to specific FDA approved therapeutic drugs.

Classification

FieldValue
Device nameImmunohistochemistry Assay, Antibody, Programmed Death-Ligand 1
Device classClass III
Review panelPA — Pathology
Medical specialtyUnknown
Premarket routePMA

Recalls for PLS devices

2 product recalls in 2 recall events; 1 initiated in the last five years and 1 still open. Most recent: 2022-11-18.

YearRecalls
20181
20221

Frequently asked questions

What is FDA product code PLS?

PLS is the FDA product code for immunohistochemistry assay, antibody, programmed death-ligand 1. It is a Class III device, reviewed by the Pathology panel.

What device class is PLS?

Class III. Typical premarket route: PMA.

Have PLS devices been recalled?

Yes: 2 product recalls across 2 recall events; the most recent began 2022-11-18.

Next steps

Compiled by Caduvo from public U.S. FDA records. Applicant names are shown as FDA records them. Review days run from FDA receipt to decision. Not reviewed or endorsed by FDA. Not regulatory advice. Report an error. Data and corrections policy.

All Pathology product codes · FDA product code lookup · 510(k) database search · 510(k) review times